Application of multi-criteria decision analysis (MCDA) scoring as an HTA methodology for off-patent pharmaceuticals (OPP) in emerging markets
期刊论文
编号：
e8668a1b-5096-4406-a999-ae02145e5dec
作者：
Brixner D., Maniadakis N., Kal贸 Z., Hu S., Johnston A., Shen J., Wijaya K.E.
地址：
[1]Personalized Health Care, University of Utah, Health Sciences Center, Salt Lake City, United States.
语种：
英文
期刊：
Value in HealthISSN：1524-47332016 年19 卷7 期 ; 1 Nov 2016
收录：
推荐引用方式 GB/T 7714：
Brixner D. Maniadakis N. Kal贸 Z. Hu S. Johnston A. Shen J. Wijaya K.E., et al. Application of multi-criteria decision analysis (MCDA) scoring as an HTA methodology for off-patent pharmaceuticals (OPP) in emerging markets [J].Value in Health,2016,19(7).
APA：
Brixner D. Maniadakis N. Kal贸 Z. Hu S. Johnston A. Shen J. Wijaya K.E..(2016).Application of multi-criteria decision analysis (MCDA) scoring as an HTA methodology for off-patent pharmaceuticals (OPP) in emerging markets .Value in Health,19(7).
MLA：
Brixner D. Maniadakis N. Kal贸 Z. Hu S. Johnston A. Shen J. Wijaya K.E., et al. "Application of multi-criteria decision analysis (MCDA) scoring as an HTA methodology for off-patent pharmaceuticals (OPP) in emerging markets" .Value in Health 19,7(2016).
Application of multi-criteria decision analysis (MCDA) scoring as an HTA methodology for off-patent pharmaceuticals (OPP) in emerging markets
作者：
Brixner D., Maniadakis N., Kal贸 Z., Hu S., Johnston A., Shen J., Wijaya K.E.
来源出版物：
Value in Health
2016 年19 卷7 期
出版日期：
2016 1 Nov 2016
ISSN/EISSN：
1524-4733
成果类型：
ds
地址：
(Brixner D.) Personalized Health Care, University of Utah, Health Sciences Center, Salt Lake City, United States. , (Maniadakis N.) National School of Public Health, Athens, Greece. , (Kal贸 Z.) E枚tv枚s Lor谩nd University, Budapest, Hungary. , (Hu S.) Fudan University, Shanghai, China. , (Johnston A.) Queen Mary University of London, London, United Kingdom. , (Shen J.) Abbott Laboratories, Abbott Park, United States. , (Wijaya K.E.) Abbott Laboratories, Allschwil, Switzerland.
(8.0+极速模式)